These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1954381

  • 1. Interleukin-6 gene expression in Castleman's disease.
    Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, Van Damme J, Galanaud P, Diebold J, Emilie D.
    Blood; 1991 Dec 01; 78(11):2923-30. PubMed ID: 1954381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
    Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, Mizobuchi K, Fujihara M, Kuraoka K, Nakai T, Ichimura K, Tanaka T, Tamura M, Nishikawa Y, Yoshino T.
    Mod Pathol; 2009 Apr 01; 22(4):589-99. PubMed ID: 19270642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome.
    Gherardi RK, Bélec L, Fromont G, Divine M, Malapert D, Gaulard P, Degos JD.
    Blood; 1994 May 01; 83(9):2587-93. PubMed ID: 8167341
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
    Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, Habermann TM, Parwaresch R.
    Am J Clin Pathol; 1996 Mar 01; 105(3):268-76. PubMed ID: 8602606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
    Momoi A, Kojima M, Sakai T, Ajiro J, Isahai N, Nagai K, Aoki S.
    Int J Hematol; 2013 Feb 01; 97(2):275-9. PubMed ID: 23359301
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
    Ishii T, Tatekawa T, Koseto M, Ishii M, Kobayashi H, Koike M, Fujii T, Saeki Y.
    Eur J Haematol; 2003 Feb 01; 70(2):115-8. PubMed ID: 12581193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.
    Screpanti I, Musiani P, Bellavia D, Cappelletti M, Aiello FB, Maroder M, Frati L, Modesti A, Gulino A, Poli V.
    J Exp Med; 1996 Oct 01; 184(4):1561-6. PubMed ID: 8879230
    [Abstract] [Full Text] [Related]

  • 16. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.
    Emilie D, Peuchmaur M, Maillot MC, Crevon MC, Brousse N, Delfraissy JF, Dormont J, Galanaud P.
    J Clin Invest; 1990 Jul 01; 86(1):148-59. PubMed ID: 2114424
    [Abstract] [Full Text] [Related]

  • 17. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
    Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y.
    Am J Pathol; 1997 Dec 01; 151(6):1517-22. PubMed ID: 9403701
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Utility of Interleukin-6 Expression by Immunohistochemistry in Differentiating Castleman Disease Subtypes and Reactive Lymphadenopathies.
    Post GR, Bell RC, Rjoop A, Lobo RH, Yuan Y, Post SR.
    Ann Clin Lab Sci; 2016 Sep 01; 46(5):474-9. PubMed ID: 27650613
    [Abstract] [Full Text] [Related]

  • 19. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K.
    Blood; 2000 Jan 01; 95(1):56-61. PubMed ID: 10607684
    [Abstract] [Full Text] [Related]

  • 20. [Expression of interleukin-6 and its clinicopathological significance in Castleman's disease].
    Lai YM, Li M, Liu CL, Huang X, Yu GH, Wang XY, Sun L, Chen J, Gao ZF.
    Zhonghua Xue Ye Xue Za Zhi; 2013 May 01; 34(5):404-8. PubMed ID: 23688750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.